Michael Zemlin

Prof. Dr. Michael Zemlin

Department for General Pediatrics and Neonatology, Saarland University Medical Center, 66421 Homburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MZMichael Zemlin
Michael Zemlin
MKMartin Klinger
Martin Klinger
JLJason M. Link
Jason M. Link
CZCosima Zemlin
Cosima Zemlin
KBKarl Bauer
Karl Bauer
PKPerry M. Kirkham
Perry M. Kirkham

17 July 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
DEDaniel Ebrahimi-Fakhari
Daniel Ebrahimi-Fakhari
LMLilian Lisa Mann
Lilian Lisa Mann
MPMartin Poryo
Martin Poryo
NGNorbert Graf
Norbert Graf
RKRüdiger von Kries
Rüdiger von Kries
Sascha MeyerSascha Meyer
Sascha Meyer
Tuberous Sclerosis Complex (TSC) is a rare multisystem disorder. In 2012 diagnostic criteria for TSC were revised. However, data on the incidence of TSC are limited. Prospective, national surveillance study in Germany over a 2-year-period (03/2015–02/2017) using current revised criteria for TSC. Patients up to the age of 18 years with a new diagnosis of definite or possible TSC (clinical and/or genetic) were included. The aims of this study were 1) to generate up-to-date data on the incidence of definite or possible TSC, 2) to assess age at first diagnosis, and 3) to compare these data with previous epidemiologic data. In total, 86 patients met inclusion criteria (definite or possible TSC) with a median age at diagnosis of 6 months (range: 5 months before birth – 197 months of age). Among patients identified with features of TSC, 73.3% met criteria for definite diagnosis (median age: 7 months) and 26.7% met criteria for a possible diagnosis (median age: 3 months). 55.8% of patients were male. When excluding prenatally diagnosed patients, median age at diagnosis was 11 months with a range of 0 to 197 months. The 3 most common clinical features at diagnosis of TSC were central nervous system involvement in 73.3% patients (of these 95.2% experienced seizures), cutaneous involvement in 58.1% patients (with the most common lesion being hypomelanotic macules in 92%) and cardiac rhabdomyoma in half of the patients. Cardiac rhabdomyoma were detected by prenatal ultrasonography in 22.1% of patients. The presence of cardiac rhabdomyoma was associated with cardiac arrhythmias in 25.6% (about 13% of all diagnosed patients) in our cohort. The overall prevalence of seizure disorders was 69.8%. The annual incidence rate of TSC is estimated at a minimum of 1:17.785 live births. However correcting for underreporting, the estimated incidence rate of definite or possible TSC is approximately 1:6.760–1:13.520 live births in Germany. This is the first study that assessed prospectively the incidence rate of TSC in children and adolescents using the updated diagnostic criteria of 2012. This prospective surveillance study demonstrates a low age at first diagnosis (median: 6 months), likely due to antenatal detection of cardiac rhabdomyoma. Early diagnosis bears the potential for implementing effective therapies at an earlier stage.

15 June 2005 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
IIIvaylo I Ivanov
Ivaylo I Ivanov
RSRobert L. Schelonka
Robert L. Schelonka
YZYingxin Zhuang
Yingxin Zhuang
GGG. Larry Gartland
G. Larry Gartland
MZMichael Zemlin
Michael Zemlin
HSHarry W. Schroeder
Harry W. Schroeder
To gain insight into the mechanisms that regulate the development of the H chain CDR3 (CDR-H3), we used the scheme of Hardy to sort mouse bone marrow B lineage cells into progenitor, immature, and mature B cell fractions, and then performed sequence analysis on VH7183-containing Cμ transcripts. The essential architecture of the CDR-H3 repertoire observed in the mature B cell fraction F was already established in the early pre-B cell fraction C. These architectural features include VH gene segment use preference, DH family usage, JH rank order, predicted structures of the CDR-H3 base and loop, and the amino acid composition and average hydrophobicity of the CDR-H3 loop. With development, the repertoire was focused by eliminating outliers to what appears to be a preferred repertoire in terms of length, amino acid composition, and average hydrophobicity. Unlike humans, the average length of CDR-H3 increased during development. The majority of this increase came from enhanced preservation of JH sequence. This was associated with an increase in the prevalence of tyrosine. With an accompanying increase in glycine, a shift in hydrophobicity was observed in the CDR-H3 loop from near neutral in fraction C (−0.08 ± 0.03) to mild hydrophilic in fraction F (−0.17 ± 0.02). Fundamental constraints on the sequence and structure of CDR-H3 are thus established before surface IgM expression.

5 June 2006 in Journal of Experimental Medicine
Verified
Journal Article
Open access
Gregory C. IppolitoGregory C. Ippolito
Gregory C. Ippolito
RSRobert L. Schelonka
Robert L. Schelonka
MZMichael Zemlin
Michael Zemlin
IIIvaylo I. Ivanov
Ivaylo I. Ivanov
RKRyoki Kobayashi
Ryoki Kobayashi
HSHarry W. Schroeder
Harry W. Schroeder
Tyrosine and glycine constitute 40% of complementarity determining region 3 of the immunoglobulin heavy chain (CDR-H3), the center of the classic antigen-binding site. To assess the role of DH RF1-encoded tyrosine and glycine in regulating CDR-H3 content and potentially influencing B cell function, we created mice limited to a single DH encoding asparagine, histidine, and arginines in RF1. Tyrosine and glycine content in CDR-H3 was halved. Bone marrow and spleen mature B cell and peritoneal cavity B-1 cell numbers were also halved, whereas marginal zone B cell numbers increased. Serum immunoglobulin G subclass levels and antibody titers to T-dependent and T-independent antigens all declined. Thus, violation of the conserved preference for tyrosine and glycine in DH RF1 alters CDR-H3 content and impairs B cell development and antibody production.

1 July 2003 in Immunity
Verified
Journal Article
Closed access
ZZZhixin Zhang
Zhixin Zhang
MZMichael Zemlin
Michael Zemlin
YWYui-Hsi Wang
Yui-Hsi Wang
DMDelicia Munfus
Delicia Munfus
LHLeslie E. Huye
Leslie E. Huye
MCMax D. Cooper
Max D. Cooper

27 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Gregory C. IppolitoGregory C. Ippolito
Gregory C. Ippolito
KHKam Hon Hoi
Kam Hon Hoi
SRSai T Reddy
Sai T Reddy
SCSean M Carroll
Sean M Carroll
XGXin Ge
Xin Ge
GGGeorge Georgiou
George Georgiou
Immunodeficient mice reconstituted with human hematopoietic stem cells enable the in vivo study of human hematopoiesis. In particular, NOD-scid-IL2Rγnull engrafted mice have been shown to have reasonable levels of T and B cell repopulation and can mount T-cell dependent responses; however, antigen-specific B-cell responses in this model are generally poor. We explored whether developmental defects in the immunoglobulin gene repertoire might be partly responsible for the low level of antibody responses in this model. Roche 454 sequencing was used to obtain over 685,000 reads from cDNA encoding immunoglobulin heavy (IGH) and light (IGK and IGL) genes isolated from immature, naïve, or total splenic B cells in engrafted NOD-scid-IL2Rγnull mice, and compared with over 940,000 reads from peripheral B cells of two healthy volunteers. We find that while naïve B-cell repertoires in humanized mice are chiefly indistinguishable from those in human blood B cells, and display highly correlated patterns of immunoglobulin gene segment use, the complementarity-determining region H3 (CDR-H3) repertoires are nevertheless extremely diverse and are specific for each individual. Despite this diversity, preferential DH-JH pairings repeatedly occur within the CDR-H3 interval that are strikingly similar across all repertoires examined, implying a genetic constraint imposed on repertoire generation. Moreover, CDR-H3 length, charged amino-acid content, and hydropathy are indistinguishable between humans and humanized mice, with no evidence of global autoimmune signatures. Importantly, however, a statistically greater usage of the inherently autoreactive IGHV4-34 and IGKV4-1 genes was observed in the newly formed immature B cells relative to naïve B or total splenic B cells in the humanized mice, a finding consistent with the deletion of autoreactive B cells in humans. Overall, our results provide evidence that key features of the primary repertoire are shaped by genetic factors intrinsic to human B cells and are principally unaltered by differences between mouse and human stromal microenvironments.